Easy Bio Inc
Easy Bio Inc is a food production company operating in the Consumer Non-Cyclicals sector, generating revenue primarily through the manufacturing and sale of food products.
Business. Easy Bio Inc (353810.KQ) is a food and beverage company operating within the Fishing & Farming industry. The firm generates revenue through the sale of products, though specific operating segments and geographic breakdowns are not disclosed. Headquartered in South Korea, the company is primarily listed on the KOSDAQ exchange.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Easy Bio Inc (353810.KQ) is a food and beverage company operating within the Fishing & Farming industry. The firm generates revenue through the sale of products, though specific operating segments and geographic breakdowns are not disclosed. Headquartered in South Korea, the company is primarily listed on the KOSDAQ exchange.
Easy Bio Inc maintains a debt-to-equity ratio of 1.43, indicating a moderate reliance on debt financing, while its current ratio of 1.35 suggests reasonable short-term liquidity. The company's return on equity of 25.91% and return on assets of 8.48% reflect strong profitability relative to its equity and asset base. However, its net cash position is negative after subtracting total debt, signaling potential liquidity constraints.
The company's operating income of 44,989,797,480 KRW and net income of 27,777,669,010 KRW demonstrate solid profitability, though the extent of its performance relative to industry medians remains unquantified due to the absence of industry_config metrics. Gross profit of 121,043,828,550 KRW supports a healthy margin structure, though the exact margin percentage is not disclosed.
Easy Bio Inc's revenue is not segmented by geographic region or product line in the available data, precluding a detailed analysis of geographic or segment concentration. Analysts estimate a 514,000,000,000 KRW revenue for the next period, suggesting a 7.7% year-over-year growth from the 476,939,000,000 KRW reported in the latest period.
The company's risk profile is characterized by medium liquidity risk and low dilution risk, though the negative net cash position after debt raises concerns about its ability to meet short-term obligations without external financing. No recent events or filings are disclosed in the input data to inform changes in risk posture or strategic direction.
The capital expenditure of -6,303,198,710 KRW indicates a reduction in investment in physical assets, which may reflect a shift in strategic focus or a response to market conditions. Analysts project an EBIT of 55,000,000,000 KRW for the next period, a 18.9% increase from the current operating income, suggesting a positive earnings outlook.
- Easy Bio Inc demonstrates strong profitability with a return on equity of 25.91% and a return on assets of 8.48%.
- The company's debt-to-equity ratio of 1.43 indicates a moderate reliance on debt financing.
- Analysts project a 7.7% year-over-year revenue growth to 514,000,000,000 KRW.
- The company's liquidity risk is assessed as medium, with a current ratio of 1.35.
- Easy Bio Inc's capital expenditure has decreased, suggesting a potential strategic shift or cost containment.
- "margin_outlook_rationale": "The company's gross profit of 121,043,828,550 KRW supports a healthy margin structure, though the exact margin percentage is not disclosed.",
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 1 236,00 |
| Revenue | —no estimate | —no estimate | 514,0B KRW |
| Operating income | —no estimate | —no estimate | 55,0B KRW |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Easy Bio Inc Market data — financials · 2026-05-26
- Easy Bio Inc Market data — analyst estimates · 2026-05-26